{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:39:46Z","timestamp":1784302786427,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":282,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.prdoa.2023.100223","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T23:26:30Z","timestamp":1697066790000},"page":"100223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-8262","authenticated-orcid":false,"given":"Bruno","family":"Bergmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.prdoa.2023.100223_b0005","first-page":"1","article-title":"The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin\u00ae)","volume":"13","author":"Morgante","year":"2020","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/practneurol-2016-001515","article-title":"Management of oral secretions in neurological disease","volume":"17","author":"McGeachan","year":"2017","journal-title":"Pract. Neurol."},{"issue":"6","key":"10.1016\/j.prdoa.2023.100223_b0015","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00455-020-10102-5","article-title":"Drooling in Parkinson\u2019s disease: prevalence and progression from the Non-motor International Longitudinal Study","volume":"35","author":"Van Wamelen","year":"2020","journal-title":"Dysphagia"},{"issue":"11","key":"10.1016\/j.prdoa.2023.100223_b0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","article-title":"Drooling in Parkinson\u2019s disease: a review","volume":"20","author":"Srivanitchapoom","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.prdoa.2023.100223_b0025","doi-asserted-by":"crossref","unstructured":"D. Santos-Garc\u00eda, T. de Deus Fonticoba, C. Cores Bartolom\u00e9, M.J. Feal Painceiras, M.C. \u00cd\u00f1iguez-Alvarado, S. Jes\u00fas, M.T. Buongiorno, L. Planellas, M. Cosgaya, J. Garc\u00eda Caldentey, N. Caballol, I. Legarda, J. Hern\u00e1ndez Vara, I. Cabo, L. L\u00f3pez Manzanares, I. Gonz\u00e1lez Aramburu, M.A. \u00c1vila Rivera, V. G\u00f3mez Mayordomo, V. Nogueira, V. Puente, J. Dotor Garc\u00eda-Soto, C. Borru\u00e9, B. Solano Vila, M. \u00c1lvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo Padilla, J.C. Mart\u00ednez Castrillo, P. S\u00e1nchez Alonso, M.G. Alonso Losada, N. L\u00f3pez Ariztegui, I. Gast\u00f3n, J. Kulisevsky, M. Bl\u00e1zquez Estrada, M. Seijo, J. R\u00faiz Mart\u00ednez, C. Valero, M. Kurtis, O. de F\u00e1bregues, J. Gonz\u00e1lez Ardura, R. Alonso Redondo, C. Ord\u00e1s, L.M.L. L\u00f3pez D\u00edaz, D. McAfee, P. Martinez-Martin, P. Mir, S.G. Coppadis. Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group, Parkinsons Dis. 6 (2023) 3104425.","DOI":"10.1155\/2023\/3104425"},{"key":"10.1016\/j.prdoa.2023.100223_b0030","doi-asserted-by":"crossref","unstructured":"S. Polychronis, G. Nasios, E. Dardiotis, L. Messinis, G. Pagano, Pathophysiology and symptomatology of drooling in Parkinson\u2019s Disease, Healthcare (Basel) 10 (3) (2022) 516.","DOI":"10.3390\/healthcare10030516"},{"key":"10.1016\/j.prdoa.2023.100223_b0035","first-page":"17","article-title":"Sialorrhea in Parkinson\u2019s disease: prevalence, impact and management strategies","volume":"9","author":"Miller","year":"2019","journal-title":"Res. Rev. Park."},{"key":"10.1016\/j.prdoa.2023.100223_b0040","doi-asserted-by":"crossref","unstructured":"J. Isaacson, S. Patel, Y. Torres-Yaghi, F. Pag\u00e1n, Sialorrhea in Parkinson\u2019s Disease, Toxins (Basel) 12 (11) (2020) 691.","DOI":"10.3390\/toxins12110691"},{"issue":"6","key":"10.1016\/j.prdoa.2023.100223_b0045","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.archoralbio.2015.03.004","article-title":"The functions of human saliva: A review sponsored by the World Workshop on Oral Medicine VI","volume":"60","author":"Dawes","year":"2015","journal-title":"Arch. Oral Biol."},{"issue":"12","key":"10.1016\/j.prdoa.2023.100223_b0050","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/0002512-200825120-00003","article-title":"Sialorrhoea and drooling in patients with Parkinson\u2019s disease: epidemiology and management","volume":"25","author":"Merello","year":"2008","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.prdoa.2023.100223_b0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","article-title":"NMSS Validation Group, The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease","volume":"26","author":"Martinez\u2010Martin","year":"2011","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100223_b0060","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00415-011-6138-2","article-title":"Diurnal and nocturnal drooling in Parkinson\u2019s disease","volume":"259","author":"Kalf","year":"2012","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100223_b0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0722.2010.00802.x","article-title":"Orofacial function and oral health in patients with Parkinson's disease","volume":"119","author":"Bakke","year":"2011","journal-title":"Eur. J. Oral Sci."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100223_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/ger.12628","article-title":"Salivation in Parkinson\u2019s disease: A scoping review","volume":"40","author":"Verhoeff","year":"2023","journal-title":"Gerodontology"},{"issue":"16","key":"10.1016\/j.prdoa.2023.100223_b0075","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/mds.21752","article-title":"Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism","volume":"22","author":"Postma","year":"2007","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.prdoa.2023.100223_b0080","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.parkreldis.2009.12.003","article-title":"The impact of and the factors associated with drooling in Parkinson\u2019s disease","volume":"16","author":"Leibner","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"3","key":"10.1016\/j.prdoa.2023.100223_b0085","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.parkreldis.2014.12.004","article-title":"Prevalence and clinical correlates of drooling in Parkinson disease: a study on 518 Chinese patients","volume":"21","author":"Ou","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.prdoa.2023.100223_b0090","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1176\/appi.neuropsych.11100315","article-title":"Motor and non-motor symptoms in Turkish patients with Parkinson\u2019s disease affecting family caregiver burden and quality of life","volume":"24","author":"Ozdilek","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.prdoa.2023.100223_b0095","doi-asserted-by":"crossref","unstructured":"K. Rosqvist, A. Schrag, P. Odin, The CLaSP Consortium. Caregiver Burden and Quality of Life in Late Stage Parkinson's Disease, Brain Sci. 12 (1) (2022) 111.","DOI":"10.3390\/brainsci12010111"},{"key":"10.1016\/j.prdoa.2023.100223_b0100","unstructured":"National Institute for Health and Care Excellence (NICE). Parkinson\u2019s disease in adults. NICE guideline NG71. [cited 2017 July 19]. Available from: https:\/\/www.parkinsons.org.uk\/professionals\/resources\/nice-guideline-ng71-parkinsons-disease-adults."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100223_b0105","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.3390\/toxins5051010","article-title":"Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins","volume":"5","author":"Lakraj","year":"2013","journal-title":"Toxins (basel)"},{"key":"10.1016\/j.prdoa.2023.100223_b0110","doi-asserted-by":"crossref","unstructured":"A. Steffen, W. Jost, T. B\u00e4umer, et al. D. Beutner, S. Degenkolb-Weyers, M. Gro\u00df, M. Grosheva, S. Hakim, K.G. Kahl, R. Laskawi, R. Lencer, J. L\u00f6hler, T. Meyners, S. Rohrbach-Volland, R. Sch\u00f6nweiler, S.-C. Schr\u00f6der, S. Schr\u00f6der, H. Schr\u00f6ter-Morasch, M. Schuster, S. Steinlechner, R. Urban, O. Guntinas-Lichius, Hypersalivation: update of the German S2k guideline (AWMF) in short form, J. Neural. Transm. (Vienna) 126 (7) (2019) 853\u2013862.","DOI":"10.1007\/s00702-019-02000-4"},{"key":"10.1016\/j.prdoa.2023.100223_b0115","unstructured":"European Parkinson\u2019s Disease Association. Sialorrhea survey report. June 2021. Available at: https:\/\/www.parkinsonseurope.org\/media\/2832\/epda-sialorrhea-survey-report.pdf."},{"issue":"3","key":"10.1016\/j.prdoa.2023.100223_b0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3233\/JPD-202078","article-title":"Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's Disease","volume":"10","author":"Radder","year":"2020","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100223_b0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/practneurol-2013-000741","article-title":"Non-motor Parkinson\u2019s: integral to motor Parkinson\u2019s, yet often neglected","volume":"14","author":"Todorova","year":"2014","journal-title":"Pract. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2023.100223_b0130","article-title":"Management of drooling of saliva","volume":"5","author":"Bavikatte","year":"2012","journal-title":"Br. J. Med. Pract."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100223_b0135","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mds.22260","article-title":"Dysautonomia rating scales in Parkinson\u2019s disease: sialorrhea, dysphagia, and constipation\u2013critique and recommendations by movement disorders task force on rating scales for Parkinson\u2019s disease","volume":"24","author":"Evatt","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2023.100223_b0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"issue":"1","key":"10.1016\/j.prdoa.2023.100223_b0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jnnp.72.1.31","article-title":"Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study","volume":"72","author":"El Sharkawi","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100223_b0155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/a-1802-3867","article-title":"Therapy of sialorrhea with botulinum toxin \u2013 an update","volume":"90","author":"Jost","year":"2022","journal-title":"Fortschr. Neurol. Psychiatr."},{"issue":"4","key":"10.1016\/j.prdoa.2023.100223_b0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamaneurol.2019.4565","article-title":"Safety and Efficacy of rimabotulinumtoxinB for Treatment of Sialorrhea in Adults: a Randomized Clinical Trial","volume":"77","author":"Isaacson","year":"2020","journal-title":"JAMA Neurol."},{"issue":"17","key":"10.1016\/j.prdoa.2023.100223_b0165","doi-asserted-by":"crossref","first-page":"e1982","DOI":"10.1212\/WNL.0000000000007368","article-title":"SIAXI: Placebo-controlled, randomized, double-blind study of incobotulinumtoxinA for sialorrhea","volume":"92","author":"Jost","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2023.100223_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2019.11.024","article-title":"Long-term incobotulinumtoxinA treatment for chronic sialorrhea: Efficacy and safety over 64 weeks","volume":"70","author":"Jost","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/mdc3.12881","article-title":"Localization of salivary glands for botulinum toxin treatment: ultrasound versus landmark guidance","volume":"7","author":"Loens","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/toxins13020087","article-title":"Use of Botulinum Neurotoxin in Parkinson's Disease: A Critical Appraisal","volume":"13","author":"Jost","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"10","key":"10.1016\/j.prdoa.2023.100223_b0185","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00276-010-0647-z","article-title":"Anatomical localization of submandibular gland for botulinum toxin injection","volume":"32","author":"Lee","year":"2010","journal-title":"Surg. Radiol. Anat."},{"key":"10.1016\/j.prdoa.2023.100223_b0190","first-page":"212","article-title":"Treatment of sialorrhea with botulinum neurotoxin type A - consensus practice recommendations for children and adults, Fortschr","volume":"90","author":"Jost","year":"2022","journal-title":"Neurol. Psychiatr."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40120-019-00155-6","article-title":"Therapy of Sialorrhea with Botulinum Neurotoxin","volume":"8","author":"Jost","year":"2019","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.prdoa.2023.100223_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2023.105712","article-title":"Parkinson's disease and oral health: A systematic review","volume":"151","author":"Verhoeff","year":"2023","journal-title":"Arch. Oral Biol."},{"issue":"5","key":"10.1016\/j.prdoa.2023.100223_b0205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10072-018-3279-4","article-title":"Saliva changes in Parkinson\u2019s disease patients after injection of Botulinum neurotoxin type A","volume":"39","author":"Tiigim\u00e4e-Saar","year":"2018","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0210","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.4317\/medoral.24101","article-title":"Oral health effects of botulinum toxin treatment for drooling: a systematic review","volume":"26","author":"Corr\u00eaa","year":"2021","journal-title":"Med. Oral Patol. Oral Cir. Bucal"},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0215","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/jnnp.2009.186239","article-title":"Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study","volume":"81","author":"Ehrt","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.prdoa.2023.100223_b0220","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mdc3.13032","article-title":"Anticholinergics may carry significant cognitive and gait burden in Parkinson's Disease","volume":"7","author":"Rajan","year":"2020","journal-title":"Mov. Disord. Clin. Pract."},{"issue":"8","key":"10.1016\/j.prdoa.2023.100223_b0225","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/phar.2305","article-title":"Association between anticholinergic medication use and risk of dementia among patients with Parkinson's disease","volume":"39","author":"Sheu","year":"2019","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.prdoa.2023.100223_b0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10639","article-title":"Increased Alzheimer pathology in Parkinson\u2019s disease related to antimuscarinic drugs","volume":"54","author":"Perry","year":"2003","journal-title":"Ann. Neurol."},{"issue":"15","key":"10.1016\/j.prdoa.2023.100223_b0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.0b013e3181d8c1b7","article-title":"J.P.P van Vugt, Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial","volume":"74","author":"Arbouw","year":"2010","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1016\/j.prdoa.2024.100250","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112523000415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T11:15:54Z","timestamp":1736507754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112523000415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":47,"alternative-id":["S2590112523000415"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100223","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.prdoa.2024.100250","asserted-by":"object"}]},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recommendations for a paradigm shift in approach to increase the recognition and treatment of sialorrhea in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2023.100223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100223"}}